Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Cambus

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 24, 2001
In vitro evaluation of the embolic risk of diagnostic and therapeutic intravascular proceduresK Zana, P Otal, B Fornet, et al.
Thrombosis and Haemostasis|October 1, 1996
D-dimer test and diagnosis of deep vein thrombosis: a comparative study of 7 assaysA Elias, I Aptel, B Huc, et al.
Thrombosis and Haemostasis|May 1, 1996
Predicting daily maintenance dose of fluindione, an oral anticoagulant drugV Cazaux, B Gauthier, A Elias, et al.
Thrombosis and Haemostasis|March 11, 1998
Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic doseB Boneu, C Navarro, J P Cambus, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosisM H Bessières, A Berrebi, S Cassaing, et al.
Thrombosis and Haemostasis|April 1, 1997
The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulabilityS Wielders, M Mukherjee, J Michiels, et al.
La Revue De Medecine Interne|March 26, 2013
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]J P Cambus, D Magnin, C Ambid-Lacombe, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 24, 2001
In vitro evaluation of the embolic risk of diagnostic and therapeutic intravascular proceduresK Zana, P Otal, B Fornet, et al.
Thrombosis and Haemostasis|October 1, 1996
D-dimer test and diagnosis of deep vein thrombosis: a comparative study of 7 assaysA Elias, I Aptel, B Huc, et al.
Thrombosis and Haemostasis|May 1, 1996
Predicting daily maintenance dose of fluindione, an oral anticoagulant drugV Cazaux, B Gauthier, A Elias, et al.
Thrombosis and Haemostasis|March 11, 1998
Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic doseB Boneu, C Navarro, J P Cambus, et al.
Memorias Do Instituto Oswaldo Cruz|May 12, 2009
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosisM H Bessières, A Berrebi, S Cassaing, et al.
Thrombosis and Haemostasis|April 1, 1997
The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulabilityS Wielders, M Mukherjee, J Michiels, et al.
La Revue De Medecine Interne|March 26, 2013
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]J P Cambus, D Magnin, C Ambid-Lacombe, et al.
Pageof 3